Septerna SEPN
NASDAQ SEPN
$39.13 -0.61 (-1.53%)
At close: Sep 29, 2026 · 4:00 PM EDT

Septerna (SEPN) EPS (Diluted) (2023 - 2026)

Updated

Septerna (SEPN) reported EPS (Diluted) of -$0.29 for Q2 2026, compared with -$0.56 a year earlier.

Analysis

Septerna (SEPN) EPS (Diluted) (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Septerna's EPS (Diluted) came in at -$0.54; for FY2025, it was -$1.10.

  • By year, EPS (Diluted) came in at -$7.26 in FY2024 and $1.92 in FY2023.
  • Five-year quarterly EPS (Diluted) spans a low of -$8.40 in Q3 2024 and a high of $16.03 in Q4 2023.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$0.19 (Q1 2026), -$0.24 (Q4 2025) and $0.18 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 2.27
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.04
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -0.54
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 1.67
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 1.85
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.37
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -8.44
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 4.31
10 Septerna 1.81 Bn 1.81 Bn - -0.29
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.29
Mar 31, 2026 -0.19
Dec 31, 2025 -0.24
Sep 30, 2025 0.18
Jun 30, 2025 -0.56
Mar 31, 2025 -0.49
Dec 31, 2024 -2.09
Sep 30, 2024 -8.40
Jun 30, 2024 -7.06
Mar 31, 2024 -6.32
Dec 31, 2023 16.03
Sep 30, 2023 -5.45
API Access

Septerna EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=SEPN&period=max&api_key=YOUR_API_KEY